Mentions
Extended reach
Total likes
Video views
AI synopsis
The collective discussions reflect a balanced view, with some quotes emphasizing the complexity of GLP-1R agonists' mechanisms and urging readers to explore detailed research, such as the comment urging consultation of Frontiers in Endocrinology. The tone varies from supportive to cautiously inquisitive, demonstrating moderate engagement and recognition of the article's significance in advancing obesity treatment methods.
Most discussions acknowledge the article as highlighting the potential of GLP-1 receptor agonists, although some question the oversimplification of their mechanisms.
Participants show moderate interest, referencing the research and noting its role in advancing obesity treatments.
Comments include citations, references to research studies, and suggestions to explore further, indicating a reasonably active level of engagement.
The discussions suggest that the publication could influence future research and clinical practices related to obesity management.
GLP-1 receptor agonists for the treatment of alcohol use disorder: buff.ly/eXYRNg2 @mayoonthebrain.bsky.social & @pact-lab.bsky.social provides a Commentary on Farokhnia et al. (buff.ly/BjP1kRB)
Review describes evidence from previous research on effects of GLP-1R agonists on #obesity. We anticipate that this review will generate data that will help biomedical researchers or clinical workers develop obesity treatments based on GLP-1R agonists. https://t.co/T1MsvogvxA https://t.co/YSVSfZiUKe
@tenobrus This is an outdated take. As others have pointed out, the issue of how GLP-1 receptor agonists work is much more complex than mere appetite suppression. I suggest you read this article from Frontiers in Endocrinology. https://t.co/F8BhRdC2VH
@WR4NYGov https://t.co/vvpGJV1QK8
New Research: GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach: Obesity is a complex disease characterized by excessive fat accumulation which is caused by genetic, environmental and other factors.… https://t.co/cDstvaOd2y #Endocrinology #Endo
RT @FrontEndocrinol: New Research: GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach: Obesity is a complex…
Discover how FDA-approved medications like liraglutide, naltrexone/bupropion, orlistat, and semaglutide work to promote weight loss. This video explains their mechanisms of action and highlights the promise of GLP-1…
Discover the groundbreaking obesity treatment Terzepatide, a once-a-week injection transforming weight loss and type 2 diabetes management. This video explores the science behind GLP1 and GIP hormones, treatment…
GLP-1 receptor agonists for the treatment of alcohol use disorder: buff.ly/eXYRNg2 @mayoonthebrain.bsky.social & @pact-lab.bsky.social provides a Commentary on Farokhnia et al. (buff.ly/BjP1kRB)
@WR4NYGov https://t.co/vvpGJV1QK8
@tenobrus This is an outdated take. As others have pointed out, the issue of how GLP-1 receptor agonists work is much more complex than mere appetite suppression. I suggest you read this article from Frontiers in Endocrinology. https://t.co/F8BhRdC2VH
Review describes evidence from previous research on effects of GLP-1R agonists on #obesity. We anticipate that this review will generate data that will help biomedical researchers or clinical workers develop obesity treatments based on GLP-1R agonists. https://t.co/T1MsvogvxA https://t.co/YSVSfZiUKe
RT @FrontEndocrinol: New Research: GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach: Obesity is a complex…
New Research: GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach: Obesity is a complex disease characterized by excessive fat accumulation which is caused by genetic, environmental and other factors.… https://t.co/cDstvaOd2y #Endocrinology #Endo